{"id":"https://openalex.org/W4393166322","doi":"https://doi.org/10.1016/j.esmoop.2024.102595","title":"16P A phase Ib/II trial to evaluate safety and efficacy of aurora kinase inhibitor LY3295668 in combination with osimertinib for patients with EGFR-mutant non-small cell lung cancer","display_name":"16P A phase Ib/II trial to evaluate safety and efficacy of aurora kinase inhibitor LY3295668 in combination with osimertinib for patients with EGFR-mutant non-small cell lung cancer","publication_year":2024,"publication_date":"2024-03-01","ids":{"openalex":"https://openalex.org/W4393166322","doi":"https://doi.org/10.1016/j.esmoop.2024.102595"},"language":"en","primary_location":{"id":"doi:10.1016/j.esmoop.2024.102595","doi":"https://doi.org/10.1016/j.esmoop.2024.102595","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.esmoop.2024.102595","pdf_url":null,"source":{"id":"https://openalex.org/S4210217024","display_name":"ESMO Open","issn_l":"2059-7029","issn":["2059-7029"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","doyens","jufo-2","ki-jl-1","medline","norway-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ESMO Open","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1016/j.esmoop.2024.102595","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5007462622","display_name":"Xiuning Le","orcid":"https://orcid.org/0000-0002-8554-1185","observed_orcids":["https://orcid.org/0000-0002-8554-1185","https://orcid.org/0009-0003-5164-3567"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"X. Le","raw_affiliation_strings":["Thoracic Head & Neck, The University of Texas MD Anderson Cancer Center, Bellaire, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thoracic Head & Neck, The University of Texas MD Anderson Cancer Center, Bellaire, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072939839","display_name":"Yasir Y. Elamin","orcid":"https://orcid.org/0000-0002-5312-909X","observed_orcids":["https://orcid.org/0000-0002-5312-909X"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Y.Y. Elamin","raw_affiliation_strings":["Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039160380","display_name":"Mehmet Altan","orcid":"https://orcid.org/0000-0001-9229-156X","observed_orcids":["https://orcid.org/0000-0001-9229-156X"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Altan","raw_affiliation_strings":["Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077579849","display_name":"George R. Blumenschein","orcid":"https://orcid.org/0000-0002-9606-8194","observed_orcids":["https://orcid.org/0000-0002-9606-8194"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"G. Blumenschein","raw_affiliation_strings":["MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067755477","display_name":"Lauren A. Byers","orcid":"https://orcid.org/0000-0002-0780-2677","observed_orcids":["https://orcid.org/0000-0002-0780-2677"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"L.A. Byers","raw_affiliation_strings":["Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062198066","display_name":"Tina Cascone","orcid":"https://orcid.org/0000-0003-3008-5407","observed_orcids":["https://orcid.org/0000-0003-3008-5407"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"T. Cascone","raw_affiliation_strings":["Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048517627","display_name":"Ferdinandos Skoulidis","orcid":"https://orcid.org/0000-0002-4676-4503","observed_orcids":["https://orcid.org/0000-0002-4676-4503"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"F. Skoulidis","raw_affiliation_strings":["Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057753889","display_name":"Carl Michael Gay","orcid":"https://orcid.org/0000-0002-4907-0718","observed_orcids":["https://orcid.org/0000-0002-4907-0718"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C. Gay","raw_affiliation_strings":["MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057281549","display_name":"Anne S. Tsao","orcid":"https://orcid.org/0000-0003-0505-6639","observed_orcids":["https://orcid.org/0000-0003-0505-6639"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A.S. Tsao","raw_affiliation_strings":["Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010884206","display_name":"Don Lynn Gibbons","orcid":"https://orcid.org/0000-0003-2362-3094","observed_orcids":["https://orcid.org/0000-0003-2362-3094"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. Gibbons","raw_affiliation_strings":["Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022661673","display_name":"Marcelo Vailati Negrao","orcid":"https://orcid.org/0000-0001-8938-6699","observed_orcids":["https://orcid.org/0000-0001-8938-6699"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M.V. Negrao","raw_affiliation_strings":["Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089322688","display_name":"Natalie I. Vokes","orcid":"https://orcid.org/0000-0002-3766-5335","observed_orcids":["https://orcid.org/0000-0002-3766-5335"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"N. Vokes","raw_affiliation_strings":["Thoracic and Head and Neck Medical Oncology, Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thoracic and Head and Neck Medical Oncology, Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111081581","display_name":"J. Zhang","orcid":"https://orcid.org/0000-0002-2178-1307","observed_orcids":["https://orcid.org/0000-0002-2178-1307"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Zhang","raw_affiliation_strings":["MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012824914","display_name":"Simon Heeke","orcid":"https://orcid.org/0000-0002-5916-534X","observed_orcids":["https://orcid.org/0000-0002-5916-534X"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. Heeke","raw_affiliation_strings":["Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005008854","display_name":"Julia K. Rotow","orcid":"https://orcid.org/0000-0003-4547-2960","observed_orcids":["https://orcid.org/0000-0003-4547-2960"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Rotow","raw_affiliation_strings":["Medical Oncology Department, The Lowe Center for Thoracic Oncology at Dana-Farber Cancer Institute, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Department, The Lowe Center for Thoracic Oncology at Dana-Farber Cancer Institute, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048675362","display_name":"Pasi Antero Janne","orcid":"https://orcid.org/0000-0002-7821-4928","observed_orcids":["https://orcid.org/0000-0002-7821-4928"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P.A. J\u00e4nne","raw_affiliation_strings":["Lowe Center for Thoracic Oncology, Dana Farber Cancer Institute, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lowe Center for Thoracic Oncology, Dana Farber Cancer Institute, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082491082","display_name":"Bruna Pellini","orcid":"https://orcid.org/0000-0003-0898-0202","observed_orcids":["https://orcid.org/0000-0003-0898-0202"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"B. Pellini","raw_affiliation_strings":["Thoracic Oncology, Moffitt Cancer Center, Tampa, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thoracic Oncology, Moffitt Cancer Center, Tampa, CA, USA","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066724438","display_name":"J. Tu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Tu","raw_affiliation_strings":["Thoracic Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thoracic Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007121755","display_name":"Jhanelle E. Gray","orcid":"https://orcid.org/0000-0003-1304-7062","observed_orcids":["https://orcid.org/0000-0003-1304-7062"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J.E. Gray","raw_affiliation_strings":["Thoracic Oncology Dept., H. Lee Moffitt Cancer Center & Research Institute - Magnolia Campus, Tampa, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thoracic Oncology Dept., H. Lee Moffitt Cancer Center & Research Institute - Magnolia Campus, Tampa, FL, USA","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5048380048","display_name":"John Victor Heymach","orcid":"https://orcid.org/0000-0001-9068-8942","observed_orcids":["https://orcid.org/0000-0001-9068-8942"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Heymach","raw_affiliation_strings":["MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3730,"currency":"USD","value_usd":3730},"apc_paid":{"value":3730,"currency":"USD","value_usd":3730},"fwci":0.5172,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.63680021,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":94,"max":96},"biblio":{"volume":"9","issue":null,"first_page":"102595","last_page":"102595"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/aurora-a-kinase-inhibitor","display_name":"Aurora A kinase inhibitor","score":0.9279999732971191},{"id":"https://openalex.org/keywords/osimertinib","display_name":"osimertinib","score":0.9929999709129333},{"id":"https://openalex.org/keywords/egfr-mutant-non-small-cell-lung-cancer","display_name":"EGFR-mutant non-small cell lung cancer","score":0.9850000143051147},{"id":"https://openalex.org/keywords/egfr-tki-resistance","display_name":"EGFR tyrosine kinase inhibitor resistance","score":0.8859999775886536},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.9079999923706055},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.7680000066757202},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.8700000047683716},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.7739999890327454},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.32899999618530273},{"id":"https://openalex.org/keywords/oral-anticancer-drugs","display_name":"oral anticancer drugs","score":0.4440000057220459},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.3540000021457672},{"id":"https://openalex.org/keywords/second-line-treatment","display_name":"second-line therapy","score":0.5019999742507935},{"id":"https://openalex.org/keywords/third-line-therapy","display_name":"third-line therapy","score":0.5090000033378601},{"id":"https://openalex.org/keywords/treatment-emergent-adverse-events","display_name":"treatment-emergent adverse events","score":0.5210000276565552},{"id":"https://openalex.org/keywords/mucositis","display_name":"mucositis","score":0.5929999947547913}],"concepts":[{"id":"https://openalex.org/C2777626846","wikidata":"https://www.wikidata.org/wiki/Q21506464","display_name":"Osimertinib","level":5,"score":0.9437510967254639},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.5803146362304688},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.5800398588180542},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5296463966369629},{"id":"https://openalex.org/C143065580","wikidata":"https://www.wikidata.org/wiki/Q3285695","display_name":"Mutant","level":3,"score":0.4550120234489441},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.44637003540992737},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4237591028213501},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.3512724041938782},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3365030884742737},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.30030733346939087},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.2576242685317993},{"id":"https://openalex.org/C2778087573","wikidata":"https://www.wikidata.org/wiki/Q418369","display_name":"Erlotinib","level":4,"score":0.059902042150497437},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.esmoop.2024.102595","doi":"https://doi.org/10.1016/j.esmoop.2024.102595","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.esmoop.2024.102595","pdf_url":null,"source":{"id":"https://openalex.org/S4210217024","display_name":"ESMO Open","issn_l":"2059-7029","issn":["2059-7029"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","doyens","jufo-2","ki-jl-1","medline","norway-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ESMO Open","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.esmoop.2024.102595","doi":"https://doi.org/10.1016/j.esmoop.2024.102595","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.esmoop.2024.102595","pdf_url":null,"source":{"id":"https://openalex.org/S4210217024","display_name":"ESMO Open","issn_l":"2059-7029","issn":["2059-7029"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","doyens","jufo-2","ki-jl-1","medline","norway-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ESMO Open","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","score":0.8299999833106995,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3184060414","https://openalex.org/W4206580764","https://openalex.org/W3112920278","https://openalex.org/W3139019175","https://openalex.org/W2582477737","https://openalex.org/W3136829214","https://openalex.org/W3205941621","https://openalex.org/W2804490319","https://openalex.org/W3164824741","https://openalex.org/W2062839819"],"abstract_inverted_index":{"In":[0,179,203,251],"preclinical":[1],"studies,":[2],"EGFR":[3,82,87],"TKI":[4],"resistant":[5],"cells":[6],"displayed":[7],"vulnerabilities":[8],"to":[9,48,92,312],"aurora":[10,18],"kinase":[11,19],"inhibitors.":[12],"LY3295668":[13,100,196,303],"is":[14],"an":[15],"oral,":[16],"selective":[17],"A":[20],"inhibitor":[21],"with":[22,79,106,232,328],"monotherapy":[23],"RP2D":[24,56,192],"at":[25,103,128,148,160,195],"25mg":[26,104,197,304],"twice-daily":[27],"(BID).":[28],"The":[29,110,191,285,300,319],"most":[30,286],"common":[31,287],"adverse":[32],"events":[33],"(AEs)":[34],"were":[35,89,98,124,139,230,247,264],"mucositis,":[36],"diarrhea":[37,290],"and":[38,52,62,84,131,146,183,224,281,296,331],"corneal":[39],"deposition.":[40],"This":[41],"phase":[42],"I/II":[43],"trial":[44],"(NCT05017025)":[45],"was":[46,101,116,171,188,193,211,310],"designed":[47],"evaluate":[49,64],"the":[50,65,69,121,180,184,204,240,252],"safety":[51,114,181],"establish":[53],"osimertinib":[54,107,200,307],"combination":[55,70,301,320],"in":[57,71,169,315],"EGFR-mutant":[58,316],"NSCLC":[59,80,317],"patients":[60],"(pts);":[61],"preliminarily":[63],"clinical":[66,336],"efficacy":[67,122,163,205],"of":[68,96,152,256,302,326],"pts":[72,138,158,246,257],"whose":[73],"tumors":[74],"progress":[75],"on":[76,86,243,249],"osimertinib.":[77],"Pts":[78],"harboring":[81],"mutations":[83],"progressed":[85],"TKIs":[88],"enrolled.":[90],"Up":[91],"3":[93,274],"prior":[94],"lines":[95],"therapies":[97],"allowed.":[99],"administered":[102],"BID":[105,198,305],"80mg":[108,201,308],"daily.":[109,202],"primary":[111],"endpoint":[112],"for":[113,120],"run-in":[115],"DLT;":[117],"co-primary":[118],"endpoints":[119],"cohort":[123,206],"progression-free":[125],"survival":[126],"(PFS)":[127],"6":[129],"months":[130],"best":[132],"objective":[133],"response":[134],"rate":[135,210,236,325],"(BRR).":[136],"30":[137],"enrolled":[140],"(Mar":[141],"2022":[142],"-":[143],"Feb":[144],"2023)":[145],"received":[147],"least":[149,161],"one":[150,162],"dose":[151],"treatment":[153],"(intent-to-treat":[154],"[ITT]":[155],"cohort);":[156],"27":[157],"had":[159,258],"scan":[164],"(efficacy":[165],"cohort).":[166],"Median":[167],"age":[168],"ITT":[170,253],"60,":[172],"77%":[173],"female,":[174],"60%":[175],"whites,":[176],"27%":[177],"Asians.":[178],"(n=10)":[182],"entire":[185],"cohort,":[186,254],"there":[187],"no":[189],"DLT.":[190],"determined":[194],"plus":[199,306],"(n=27),":[207],"6-month":[208,323],"PFS":[209,324],"37%":[212,327],"(10/27).":[213],"Three":[214],"partial":[215],"responses":[216],"(PRs,":[217],"11%),":[218],"17":[219],"stable":[220],"diseases":[221,227],"(SD,":[222],"63%)":[223],"7":[225],"progressive":[226],"(PD,":[228],"26%)":[229],"observed,":[231],"a":[233,322],"disease":[234],"control":[235],"(DCR":[237],"74%).":[238],"At":[239],"data":[241],"cut-off":[242],"12/12/2023,":[244],"5":[245],"still":[248],"treatment.":[250],"100%":[255],"any":[259],"AEs.":[260],"Treatment-related":[261],"AEs":[262],"(TRAEs)":[263],"80%,":[265],"including":[266],"3%":[267],"grade":[268,273,283],"4":[269],"(n=1,":[270],"thrombocytopenia),":[271],"13%":[272],"(thrombocytopenia,":[275],"lymphopenia,":[276],"neutropenia,":[277],"diarrhea,":[278],"abdominal":[279],"pain),":[280],"63%":[282,332],"1-2.":[284],"TRAEs":[288],"are":[289],"(73%),":[291],"thrombocytopenia":[292],"(60%),":[293],"anemia":[294],"(47%)":[295],"elevated":[297],"transaminases":[298],"(47%).":[299],"daily":[309],"found":[311],"be":[313],"safe":[314],"pts.":[318],"yields":[321],"11%":[329],"PR":[330],"SD,":[333],"demonstrating":[334],"moderate":[335],"efficacy.":[337]},"counts_by_year":[{"year":2025,"cited_by_count":2}],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2025-10-10T00:00:00"}